> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letter
- URL: https://www.fdaweb.com/latest-fda-warning-letter-7/
- Published: 2020-07-14T12:00:00.000Z
- Updated: 2026-09-14T16:21:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147190

FDA has posted its latest batch of Warning Letters that includes one medical product company. It can be accessed by clicking on the link following the summary below:  

**Kegan Wellness**, Ahmedabad, India (7/13): FDA recently reviewed the firm’s Internet address and social media sites and determined that vitamin tablets offered for sale are unapproved new drugs. The Warning Letter objected to product claims such as “Boost Your Immunity” and “May help to prevent Covid-19 symptoms by supporting to \[*sic*\] increase immunity.” The letter requests an email describing actions taken to correct the violations. To view the Warning Letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kegan-wellness-608737-07132020?ref=fdaweb.com).